A Novel Aptamer LL4A Specifically Targets Vemurafenib-Resistant Melanoma through Binding to the CD63 Protein
Article in Molecular Therapy - Nucleic Acids (October 2019)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Involvement of TIMP-1 in PECAM-1-mediated tumor dissemination
Article in International Journal of Oncology (May 2018)
Detection of Circulating Tumor Cells in Patients with Breast, Prostate, Pancreatic, Colon and Melanoma Cancer: A Blinded Comparative Study Using Healthy Donors
Article in Journal of Cancer Therapy (July 2015)